InsiderClue
← All stocks

Hemab Therapeutics Holdings, Inc.

COAG Net buying
CIK 0002114044 #1956 in the set updated 17 Sep 2026
Bought (12 mo)
$55.46M
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$55.46M
+$55.46M against sales at will

By person

3 insiders · 16 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
RA CAPITAL MANAGEMENT, L.P. entity
10% owner
$55.46M (16)
—
+$55.46M
6,444,637
13.80%
$160.99M
—
Novo Holdings A/S entity
10% owner
—
—
—
4,180,550
8.95%
$104.43M
—
MARAGANORE JOHN
Director
—
—
—
35,948
0.0770%
$897.98K
—

Individual transactions

16
Insider
Date
Role
Action
Shares
Price
Amount
RA CAPITAL MANAGEMENT, L.P.
16 Jun 2026
10% owner
Buy indirect
61,523
$24.98
$1.54M
RA CAPITAL MANAGEMENT, L.P.
15 Jun 2026
10% owner
Buy indirect
6,146
$24.89
$152.97K
RA CAPITAL MANAGEMENT, L.P.
20 May 2026
10% owner
Buy indirect
996
$24.94
$24.84K
RA CAPITAL MANAGEMENT, L.P.
19 May 2026
10% owner
Buy indirect
3,802
$24.97
$94.94K
RA CAPITAL MANAGEMENT, L.P.
12 May 2026
10% owner
Buy indirect
6,387
$24.90
$159.04K
RA CAPITAL MANAGEMENT, L.P.
11 May 2026
10% owner
Buy indirect
25,720
$25.00
$643.00K
RA CAPITAL MANAGEMENT, L.P.
11 May 2026
10% owner
Buy indirect
14,149
$24.47
$346.23K
RA CAPITAL MANAGEMENT, L.P.
8 May 2026
10% owner
Buy indirect
1,483
$24.98
$37.05K
RA CAPITAL MANAGEMENT, L.P.
7 May 2026
10% owner
Buy indirect
1,985
$24.95
$49.53K
RA CAPITAL MANAGEMENT, L.P.
7 May 2026
10% owner
Buy indirect
7,921
$24.34
$192.80K
RA CAPITAL MANAGEMENT, L.P.
6 May 2026
Director
Buy indirect
53,407
$24.83
$1.33M
RA CAPITAL MANAGEMENT, L.P.
6 May 2026
Director
Buy indirect
14,611
$23.77
$347.30K
RA CAPITAL MANAGEMENT, L.P.
5 May 2026
Director
Buy indirect
10,268
$25.00
$256.70K
RA CAPITAL MANAGEMENT, L.P.
5 May 2026
Director
Buy indirect
87,143
$24.59
$2.14M
RA CAPITAL MANAGEMENT, L.P.
4 May 2026
Director
Buy indirect
133,750
$18.00
$2.41M
RA CAPITAL MANAGEMENT, L.P.
4 May 2026
Director
Buy indirect
2,541,250
$18.00
$45.74M

What was left out

Form 4 filings counted 9
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 9,054,584
History held since 4 May 2026